Ixcela

Ixcela

⭐ Hyper-personalized health solutions | ❤️ Root-cause support for sleep, energy, and digestion | 🥦 Licensed RDNs

Founded 2012

Beverly, United States 16 employees Venture round Total: $7.99M Biotechnology, Health Care

Ixcela, a Boston-based biotech company, is dedicated to providing data-driven wellness through a pinprick of blood. Their slogan, "The Internal Fitness™ Company," reflects their commitment to helping individuals look and feel great, improve athletic performance, and manage chronic health conditions. Ixcela's key offering is a gut microbiome test that provides actionable results. This test forms the basis for personalized fitness plans, nutrition advice, and supplement recommendations, helping individuals restore their internal fitness. Founded in 2012, Ixcela operates in the biotechnology and health care industries. The company's recent milestone includes securing a $3.82Mventure Round investment from iD Ventures America on 14 October 2020. With a focus on the gut as the "second brain," Ixcela acknowledges the impact of lifestyle choices on internal biochemistry, connecting poor internal fitness to common health issues and chronic diseases. By offering specific, actionable steps, Ixcela empowers individuals to take control of their wellness and adapt their personalized wellness plan through regular retesting. This innovative approach positioned Ixcela as a promising player in the biotech and wellness sectors.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	$3.82M	1	iD Ventures America	14 Oct 2020
Venture Round	$1.82M	-		20 Jul 2017
Seed Round	$2.35M	-		15 Jul 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

$3.82M

iD Ventures America

14 Oct 2020

Venture Round

$1.82M

20 Jul 2017

Seed Round

$2.35M

15 Jul 2015

FAQ About Ixcela

⭐ Hyper-personalized health solutions | ❤️ Root-cause support for sleep, energy, and digestion | 🥦 Licensed RDNs

Ixcela was founded in 2012.

Ixcela is headquartered in Beverly, United States.

Ixcela operates in Biotechnology and Health Care. Its work centres on Biotech, Wellness, Gut microbiome testing and Data-driven.

Ixcela has approximately 16 employees.

Ixcela has completed 3 funding rounds, raising a total of $7.99M. The latest funding stage is Venture round.

Top alternatives and competitors to Ixcela include AnimalBiome, Tiny Health, Flore by Sun Genomics, Sugarlogix, DayTwo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Ixcela and AnimalBiome are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Ixcela

Funding Rounds & Investors (3)

Ixcela Alternatives & Competitors

FAQ About Ixcela